Latest News and Press Releases

Vilobelimab is the first authorized drug to control complement factor C5a, a protein that plays an important and often harmful role in the body's immune responseFDA granted EUA based on Phase III...

Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...

NORTH CHICAGO, Ill., March 16, 2023 (GLOBE NEWSWIRE) -- AirAnswers® has announced a new partnership today with Totally Safe Air. AirAnswers and Totally Safe Air join forces to identify and eliminate...

ExeVir Bio and VIB-UGent’s bioRxiv pre-print reports on S2-binding camelid single-domain antibody-based drug, XVR013, that targets the Achilles’ heel in the SARS-CoV-2 viral spikeFocus on protecting...

SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- The COVID-19 Detection Foundation (dba Virufy), a 501(c)(3) non-profit research organization (https://virufy.org) developing a smartphone app for...

MIAMI, March 03, 2023 (GLOBE NEWSWIRE) -- eMed, the leader in at-home, test-to-treat telehealth kits, today announced the first-of-its-kind eMed® Urgent Care Telehealth Kit™. Powered by eMed's...

NORTH CHICAGO, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- AirAnswers, the leader in air sampling and testing technology, is expanding their test offering to include a panel of airborne viruses...

TORONTO, 01 mars 2023 (GLOBE NEWSWIRE) -- La Fondation pour l’alphabétisation des enfants canadiens lance une galerie virtuelle publique présentant des histoires et des œuvres artistiques racontées...

TORONTO, March 01, 2023 (GLOBE NEWSWIRE) -- The Canadian Children’s Literacy Foundation is launching an online public gallery featuring stories and art by children from across Canada about their...

TORONTO, 28 févr. 2023 (GLOBE NEWSWIRE) -- La Fondation pour l’alphabétisation des enfants canadiens lance une galerie virtuelle publique présentant des histoires et des œuvres artistiques...